SIEGALL CLAY B bought IMNM
March 27, 2026 · Form 4 insider transaction
SIEGALL CLAY B bought 25,450 shares of Immunome, Inc. at $19.67 per share, a transaction worth $500.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,450
Price
$19.67
Total value
$500.6K
InsiderSIEGALL CLAY B
RoleOfficer, Director
CompanyImmunome, Inc. (IMNM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 27, 2026
Filing dateMarch 31, 2026
Shares owned after690,704
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average purchase price for the transaction report was $19.67, and the range of prices were between $19.63 and $19.70, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.